Filter
6117
Filtered Results: 6117
Text search:
drug
treatment
Featured
Recommendations
533
New Publications
1506
Language
Document type
No document type
3616
Studies & Reports
924
Guidelines
767
Manuals
276
Strategic & Response Plan
183
Fact sheets
127
Training Material
91
Situation Updates
57
Infographics
29
Resource Platforms
20
Brochures
17
Online Courses
7
Videos
2
App
1
Countries / Regions
India
371
Global
194
Kenya
177
South Africa
152
Western and Central Europe
131
Ethiopia
130
Uganda
124
Nigeria
115
Tanzania
110
Nepal
103
Africa
91
Liberia
91
Sierra Leone
90
Zambia
90
Latin America and the Carribbean
88
Malawi
87
Myanmar / Burma
75
Ghana
74
Bangladesh
74
Eastern Europe
71
Ukraine
65
Namibia
64
Rwanda
62
Philippines
49
Zimbabwe
47
Asia
47
Russia
45
Indonesia
41
Lesotho
38
Cambodia
37
South–East Asia Region
35
Mozambique
32
Botswana
30
Senegal
29
Congo, Democratic Republic of
27
Syria
25
Germany
25
Brazil
25
Eswatini/ Swaziland
23
Colombia
21
Burkina Faso
20
East and Southern Africa
20
South Sudan
19
Venezuela
17
Cameroon
15
West and Central Africa
15
USA
14
Haiti
14
Middle East and North Africa
14
Eastern Europe and Central Asia
14
Thailand
12
Albania
12
Pakistan
12
Tajikistan
11
China
11
Guinea
11
Georgia
11
Argentina
10
Vietnam
10
Afghanistan
9
Sudan
9
Peru
8
Yemen
7
North Macedonia
6
El Salvador
6
Benin
6
Armenia
6
Western Pacific Region
6
North America
6
Bolivia
6
Moldova
6
Sri Lanka
6
Angola
6
Mexico
5
Laos
5
Lebanon
5
Papua New Guinea
5
Iraq
5
Somalia
5
Timor Leste/ East Timor
4
Iran
4
Estonia
4
Guinea-Bissau
4
Jordan
4
Paraguay
4
Jamaica
4
United Kingdom
4
Central African Republic
4
Mali
4
Libya
4
Bhutan
4
Ecuador
4
Switzerland
3
Turkey
3
Fiji
3
Kyrgyzstan
3
Uzbekistan
3
Morocco
3
Spain
3
Palestine
3
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Mongolia
2
Hungary
2
Saudi Arabia
2
France
2
Portugal
2
Belarus
2
Southern Africa
2
Romania
2
Poland
2
Honduras
2
Chad
2
Madagascar
2
North Korea
1
Australia
1
Gambia
1
Singapore
1
Malaysia
1
Qatar
1
Bulgaria
1
Italy
1
Dominican Republic
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Côte d’Ivoire / Ivory Coast
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Nicaragua
1
Egypt
1
Greece
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2300
Clinical Guidelines
548
Public Health
272
Women & Child Health
218
Key Resources
143
Capacity Building
102
Pharmacy & Technologies
64
Annual Report MEDBOX
1
Toolboxes
HIV
762
TB
691
Mental Health
640
NTDs
287
AMR
284
COVID-19
239
Pharmacy
179
NCDs
137
Malaria
119
Caregiver
116
Ebola & Marburg
94
Refugee
83
Conflict
62
Rapid Response
61
Disability
60
Planetary Health
60
Global Health Education
50
Health Financing Toolbox
41
2.0 Rapid Response
27
Polio
24
Cholera
23
Specific Hazards
19
Natural Hazards
17
Zika
17
Social Ethics
16
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
Best practice portal: standards and guidelines
recommended
The Best practice portal is a resource for professionals, policymakers and researchers in the drugs field. We provide information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the European context. The evidence is compiled following an explicit metho...
Best Practice Portal
recommended
The Best practice portal is designed to help you find practical and reliable information on what works (and what doesn’t) in the areas of prevention, treatment, harm reduction and social reintegration. It will help you identify tried and tested interventions quickly, allocate resources to what's e...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
The pamphlet "Oxycodone" provides an overview of the opioid drug class, explaining its uses, effects, and risks. It describes positive effects like euphoria and pain relief, alongside negative effects such as respiratory depression, confusion, and constipation. Withdrawal symptoms include anxiety, i...
Protocol for the management of specialized centres for the treatment of people with alcohol and other drug abuse problems (CETAD) in the framework of the COVID-19 pandemic. Version 1.
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
Combination therapy is a cornerstone of modern malaria treatment, particularly in the context of widespread multidrug resistance. Using two or more antimalarial drugs with different mechanisms simultaneously enhances efficacy, shortens treatment duration, improves compliance and delays the developme...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The pamphlet "What is Addiction" explains addiction as a chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences. It highlights the dangers of different drug categories, including sedatives, stimulants, and hallucinogens, and their potential he...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
The World Health Organization's fact sheet on opioid overdose highlights the significant global health issue posed by opioids, which include natural, semi-synthetic, and synthetic compounds used primarily for pain management. Misuse and unsupervised use can lead to dependence and severe health probl...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Antimalarial chemotherapy is crucial for reducing morbidity, mortality, and drug resistance, and is the cornerstone of malaria control. Existing antimalarial drugs act at different stages of the parasite’s life cycle. These drugs range from classic agents such as chloroquine and quinine to newer a...
Substance abuse, is a dangerous relapsing brain disease requiring intensive treatment in a professional setting. Someone who is suffering from substance abuse will have cravings and compulsive drug use that persists even in the face of negative consequences. Although substance abuse may start out as...
BMC Infectious Diseases (2019) 19:832
Intestinal schistosomiasis is highly endemic in Tanzania and mass drug administration (MDA) using
praziquantel is the mainstay of the control program. However, the MDA program covers only school aged children
and does not include neither adult individuals nor...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
